Robert Egge is the chief public policy officer of the Alzheimer's Association and the president of the Alzheimer's Impact Movement (AIM), a separately incorporated advocacy affiliate of the Association. Egge oversees government affairs, policy development and grassroots advocacy teams working to secure policies to improve the lives of all those affected by dementia.

With his leadership, the Alzheimer's Association and AIM have empowered thousands of people across the country impacted by dementia to become grassroots advocates. These individuals have been trained and mobilized to share their stories about dementia, creating a personal connection between elected officials and the people impacted by their positions on our issues.

Egge has led the Association in achieving several major federal milestones, including the passage of the National Alzheimer's Project Act (NAPA), which mandated the creation of the first national plan to fight Alzheimer's, and a more than seven-fold increase in federal Alzheimer's and dementia research funding to $3.9 billion annually. In 2024, Congress renewed its bipartisan commitment to addressing Alzheimer's and other dementia by passing the NAPA Reauthorization Act and the Alzheimer's Accountability and Investment Act.

He has also led efforts resulting in unprecedented progress at the state level, with state dementia-specific funding increasing 488% over the last decade. In 2025, Egge led the Association's successful efforts to grow support for Proposition 14 in Texas, which established the largest state-funded dementia research initiative in the nation with the Dementia Prevention and Research Institute of Texas (DPRIT).

Egge has also overseen major advances in dementia care, including a 2016 decision by the Centers for Medicare & Medicaid Services (CMS) to ensure, for the first time in history, that people living with dementia have access to care planning with a medical professional through Medicare. More recently, he led efforts to ensure that CMS established coverage for FDA‑approved Alzheimer's treatments — a milestone that expanded access to innovative therapies for millions of Americans. Bipartisan congressional support and grassroots advocacy for the Association's priority bill, the Comprehensive Care for Alzheimer's Act, also contributed to CMS announcing the GUIDE Model, the country's most important dementia care initiative ever undertaken.

Growing support in the community for families living with dementia is also a priority for Egge. He managed the Association's work to pass the bipartisan BOLD Infrastructure for Alzheimer's Act, legislation that led to the establishment of a Centers for Disease Control and Prevention (CDC) grant program that provides funds to state and local health departments to allow states to grow a statewide public health infrastructure that increases early detection and diagnosis, risk reduction, prevention of avoidable hospitalizations and supports dementia caregiving. This critical legislation was reauthorized in 2024.

From 2017-2021, Egge served on the U.S. Department of Health and Human Services' (HHS) Advisory Council on Alzheimer's Research, Care and Services. This advisory council, created by NAPA, provides guidance to both the HHS Secretary and Congress on Alzheimer's policy.

Egge has also been recognized for four consecutive years on The Hill's annual list of Top Lobbyists, most recently in 2025, reflecting his national leadership in advancing bipartisan policies supporting individuals living with Alzheimer's and other dementia.